Adrenal Imaging: A Comprehensive Review

Radiologic Clinics of North America

Volumn 50, Issue 2, 2012, Pages 219-243

  Taffel, Myles ^a   Haji Momenian, Shawn ^b   Nikolaidis, Paul ^c   Miller, Frank H ^c  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b Feinberg School of Medicine ^*

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adrenal adenoma; Adrenal characterization; Adrenal neoplasm

Indexed keywords

ADRENAL CANCER; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL CYST; ADRENAL DISEASE; ADRENAL HEMORRHAGE; ADRENAL IMAGING; ADRENAL INCIDENTALOMA; ADRENAL LYMPHOMA; ADRENAL METASTASIS; ALGORITHM; COLLISION TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DUAL ENERGY COMPUTER ASSISTED TOMOGRAPHY; GANGLIONEUROMA; HEMANGIOMA; HUMAN; INFECTION; INTERMETHOD COMPARISON; MEDICAL SOCIETY; MYELOLIPOMA; NEUROBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; UNITED STATES;

ADRENAL GLAND NEOPLASMS; ALGORITHMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INCIDENTAL FINDINGS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84859483141     PISSN: 00338389     EISSN: 15578275     Source Type: Journal    
DOI: 10.1016/j.rcl.2012.02.009     Document Type: Review

References (123)

1. Kloos R.T., Gross M.D., Francis I.R., et al. Incidentally discovered adrenal masses. Endocr Rev 1995, 16(4):460-484.
2. Zeiger M.A., Siegelman S.S., Hamrahian A.H. Medical and surgical evaluation and treatment of adrenal incidentalomas. J Clin Endocrinol Metab 2011, 96(7):2004-2015.
3. Berland L.L., Silverman S.G., Gore R.M., et al. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol 2010, 7(10):754-773.
4. Boland G.W., Lee M.J., Gazelle G.S., et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 1998, 171(1):201-204.
5. Young W.F. The incidentally discovered adrenal mass. N Engl J Med 2007, 356(6):601-610.
6. Song J.H., Chaudhry F.S., Mayo-Smith W.W. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. Am J Roentgenol 2008, 190(5):1163-1168.
7. Grumbach M.M., Biller B.M., Braunstein G.D., et al. Management of the clinically inapparent adrenal mass (" incidentaloma" ). Ann Intern Med 2003, 138:424-429.
8. Young W.F. The adrenal incidentiloma. UpToDate 2012, Waltham (MA). D.S. Basow (Ed.).
9. Young W.F. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 2000, 29(1):159-185. x.
10. Management of the clinically inapparent adrenal mass (incidentaloma). U.S. Department of Health & Human Services, National Institutes of Health Web site. Available at: Accessed February 11, 2012. http://consensus.nih.gov/2002/2002AdrenalIncidentalomasos021html.htm.
11. Choyke P.L. ACR Committee on Appropriateness Criteria. ACR Appropriateness Criteria on incidentally discovered adrenal mass. J Am Coll Radiol 2006, 3(7):498-504.
12. Lee M.J., Hahn P.F., Papanicolaou N., et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991, 179(2):415-418.
13. Korobkin M., Giordano T.J., Brodeur F.J., et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 1996, 200(3):743-747.
14. Boland G.W., Blake M.A., Hahn P.F., et al. Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology 2008, 249(3):756-775.
15. Savci G., Yazici Z., Sahin N., et al. Value of chemical shift subtraction MRI in characterization of adrenal masses. AJR Am J Roentgenol 2006, 186(1):130-135.
16. Mayo-Smith W., Lee M., McNicholas M., et al. Characterization of adrenal masses. Am J Roentgenol 1995, 165(1):91.
17. Israel G.M., Korobkin M., Wang C., et al. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR Am J Roentgenol 2004, 183(1):215-219.
18. Otal P., Escourrou G., Mazerolles C., et al. Imaging features of uncommon adrenal masses with histopathologic correlation. Radiographics 1999, 19(3):569-581.
19. McNicholas M.M., Lee M.J., Mayo-Smith W.W., et al. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. AJR Am J Roentgenol 1995, 165(6):1453-1459.
20. Fujiyoshi F., Nakajo M., Fukukura Y., et al. Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation. Am J Roentgenol 2003, 180(6):1649.
21. Outwater E., Siegelman E., Huang A., et al. Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 1996, 200(3):749.
22. Haider M.A., Ghai S., Jhaveri K., et al. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?. Radiology 2004, 231(3):711-716.
23. Szolar D.H., Kammerhuber F. Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas?. Radiology 1997, 202(2):517-521.
24. Boland G.W., Hahn P.F., Peña C., et al. Adrenal masses: characterization with delayed contrast-enhanced CT. Radiology 1997, 202(3):693-696.
25. Korobkin M., Brodeur F.J., Francis I.R., et al. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 1998, 170(3):747-752.
26. Caoili E.M., Korobkin M., Francis I.R., et al. Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 2000, 175(5):1411-1415.
27. Blake M.A., Kalra M.K., Sweeney A.T., et al. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 2006, 238(2):578-585.
28. Sangwaiya M.J., Boland G.W.L., Cronin C.G., et al. Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT-10-minute delayed imaging protocol revisited in a large patient cohort. Radiology 2010, 256(2):504-510.
29. Lam K.Y., Lo C.Y. Adrenal lipomatous tumours: a 30 year clinicopathological experience at a single institution. J Clin Pathol 2001, 54(9):707-712.
30. Patel V.G., Babalola O.A., Fortson J.K., et al. Adrenal myelolipoma: report of a case and review of the literature. Am Surg 2006, 72(7):649-654.
31. Meyer A., Behrend M. Presentation and therapy of myelolipoma. Int J Urol 2005, 12(3):239-243.
32. Israel G.M., Hindman N., Hecht E., et al. The use of opposed-phase chemical shift MRI in the diagnosis of renal angiomyolipomas. AJR Am J Roentgenol 2005, 184(6):1868-1872.
33. Kenney P.J., Wagner B.J., Rao P., et al. Myelolipoma: CT and pathologic features. Radiology 1998, 208(1):87-95.
34. Zhang H.M., Perrier N.D., Grubbs E.G., et al. CT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies. Clin Radiol 2012, 67(1):38-46.
35. Rana A.I., Kenney P.J., Lockhart M.E., et al. Adrenal gland hematomas in trauma patients. Radiology 2004, 230(3):669-675.
36. Nimkin K., Teeger S., Wallach M.T., et al. Adrenal hemorrhage in abused children: imaging and postmortem findings. AJR Am J Roentgenol 1994, 162(3):661-663.
37. Westra S.J., Zaninovic A.C., Hall T.R., et al. Imaging of the adrenal gland in children. Radiographics 1994, 14(6):1323-1340.
38. Hinrichs C.R., Singer A., Maldjian P., et al. Inferior vena cava thrombosis: a mechanism of posttraumatic adrenal hemorrhage. AJR Am J Roentgenol 2001, 177(2):357-358.
39. Xarli V.P., Steele A.A., Davis P.J., et al. Adrenal hemorrhage in the adult. Medicine (Baltimore) 1978, 57(3):211-221.
40. Ten S., New M., Maclaren N. Clinical review 130: Addison's disease 2001. J Clin Endocrinol Metab 2001, 86(7):2909-2922.
41. Dunnick N.R. Hanson lecture. Adrenal imaging: current status. AJR Am J Roentgenol 1990, 154(5):927-936.
42. Rozenblit A., Morehouse H.T., Amis E.S. Cystic adrenal lesions: CT features. Radiology 1996, 201(2):541-548.
43. Foster D. Adrenal cysts: review of literature and report of case. Arch Surg 1966, 92(1):131-143.
44. Guo Y.K., Yang Z.G., Li Y., et al. Uncommon adrenal masses: CT and MRI features with histopathologic correlation. Eur J Radiol 2007, 62(3):359-370.
45. Lenert J.T., Barnett C.C., Kudelka A.P., et al. Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery 2001, 130(6):1060-1067.
46. Gillams A., Roberts C., Shaw P., et al. The value of CT scanning and percutaneous fine needle aspiration of adrenal masses in biopsy-proven lung cancer. Clin Radiol 1992, 46(1):18-22.
47. Belldegrun A., Hussain S., Seltzer S. Incidentally discovered mass of the adrenal gland. Surg Gynecol Obstet 1986, 163(3):203-208.
48. Korobkin M. Overview of adrenal imaging/adrenal CT. Urol Radiol 1989, 11(4):221-226.
49. Abrams H.L., Spiro R., Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 1950, 3(1):74-85.
50. Lee J.E., Evans D.B., Hickey R.C., et al. Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. Surgery 1998, 124(6):1115-1122.
51. Blake M.A., Cronin C.G., Boland G.W. Adrenal imaging. AJR Am J Roentgenol 2010, 194(6):1450-1460.
52. Boland G.W., Dwamena B.A., Sangwaiya M.J., et al. Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology 2011, 259(1):117-126.
53. Metser U., Miller E., Lerman H., et al. 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 2006, 47(1):32-37.
54. Boland G.W., Blake M.A., Holalkere N.S., et al. PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. Am J Roentgenol 2009, 192(4):956-962.
55. Vikram R., Yeung H.D., Macapinlac H.A., et al. Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer. Am J Roentgenol 2008, 191(5):1545-1551.
56. Schwartz L.H., Macari M., Huvos A.G., et al. Collision tumors of the adrenal gland: demonstration and characterization at MR imaging. Radiology 1996, 201(3):757-760.
57. Singh D., Kumar L., Sharma A., et al. Adrenal involvement in Non-Hodgkin's lymphoma: four cases and review of literature. Leuk Lymphoma 2004, 45(4):789-794.
58. Zhou L., Peng W., Wang C., et al. Primary adrenal lymphoma: radiological; pathological, clinical correlation. Eur J Radiol 2012, 81(3):401-405.
59. Kato H., Itami J., Shiina T., et al. MR imaging of primary adrenal lymphoma. Clin Imaging 1996, 20(2):126-128.
60. Palling M.R., Williamson B.R. Adrenal involvement in non-Hodgkin lymphoma. AJR Am J Roentgenol 1983, 141(2):303-305.
61. Hussain H.K., Korobkin M. MR imaging of the adrenal glands. Magn Reson Imaging Clin N Am 2004, 12(3):515-544. vii.
62. Sohaib S.A., Reznek R.H. Adrenal imaging. BJU Int 2000, 86(Suppl 1):95-110.
63. Cho K.J., Freier D.T., McCormick T.L., et al. Adrenal medullary disease in multiple endocrine neoplasia type II. AJR Am J Roentgenol 1980, 134(1):23-29.
64. Demos T.C., Blonder J., Schey W.L., et al. Multiple endocrine neoplasia (MEN) syndrome type IIB: gastrointestinal manifestations. AJR Am J Roentgenol 1983, 140(1):73-78.
65. Szolar D.H., Korobkin M., Reittner P., et al. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 2005, 234(2):479-485.
66. Newhouse J.H., Heffess C.S., Wagner B.J., et al. Large degenerated adrenal adenomas: radiologic-pathologic correlation. Radiology 1999, 210(2):385-391.
67. Andreoni C., Krebs R.K., Bruna P.C., et al. Cystic phaeochromocytoma is a distinctive subgroup with special clinical, imaging and histological features that might mislead the diagnosis. BJU Int 2008, 101(3):345-350.
68. Park B.K., Kim C.K., Kwon G.Y., et al. Re-evaluation of pheochromocytomas on delayed contrast-enhanced CT: washout enhancement and other imaging features. Eur Radiol 2007, 17(11):2804-2809.
69. Ramsay J.A., Asa S.L., van Nostrand A.W., et al. Lipid degeneration in pheochromocytomas mimicking adrenal cortical tumors. Am J Surg Pathol 1987, 11(6):480-486.
70. Blake M.A., Krishnamoorthy S.K., Boland G.W., et al. Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. AJR Am J Roentgenol 2003, 181(6):1663-1668.
71. Blake M.A., Kalra M.K., Maher M.M., et al. Pheochromocytoma: an imaging chameleon. Radiographics 2004, 24(Suppl 1):S87-S99.
72. Quint L.E., Glazer G.M., Francis I.R., et al. Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy. Radiology 1987, 165(1):89-93.
73. van Gils A.P., Falke T.H., van Erkel A.R., et al. MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas. Radiographics 1991, 11(1):37-57.
74. Rha S.E., Byun J.Y., Jung S.E., et al. Neurogenic tumors in the abdomen: tumor types and imaging characteristics. Radiographics 2003, 23(1):29-43.
75. Francis I.R., Korobkin M. Pheochromocytoma. Radiol Clin North Am 1996, 34(6):1101-1112.
76. Kim S., Salibi N., Hardie A.D., et al. Characterization of adrenal pheochromocytoma using respiratory-triggered proton MR spectroscopy: initial experience. Am J Roentgenol 2009, 192(2):450-454.
77. Park B.K., Kim B., Ko K., et al. Adrenal masses falsely diagnosed as adenomas on unenhanced and delayed contrast-enhanced computed tomography: pathological correlation. Eur Radiol 2006, 16(3):642-647.
78. Yoon J.K., Remer E.M., Herts B.R. Incidental pheochromocytoma mimicking adrenal adenoma because of rapid contrast enhancement loss. Am J Roentgenol 2006, 187(5):1309-1311.
79. Caoili E.M., Korobkin M., Francis I.R., et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 2002, 222(3):629-633.
80. Wiseman G.A., Pacak K., O'Dorisio M.S., et al. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J Nucl Med 2009, 50(9):1448-1454.
81. Tenenbaum F., Lumbroso J., Schlumberger M., et al. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med 1995, 36(1):1-6.
82. Rozovsky K., Koplewitz B.Z., Krausz Y., et al. Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma. Am J Roentgenol 2008, 190(4):1085-1090.
83. Shulkin B.L., Thompson N.W., Shapiro B., et al. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET. Radiology 1999, 212(1):35-41.
84. Ilias I., Yu J., Carrasquillo J.A., et al. Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 2003, 88(9):4083-4087.
85. Arnold D, Villemagne V, Civelek A. FDG-PET: a sensitive tool for the localization of MIBG negative pelvic pheochromocytomas. The .... 1998.
86. Raisanen J., Shapiro B., Glazer G.M., et al. Plasma catecholamines in pheochromocytoma: effect of urographic contrast media. AJR Am J Roentgenol 1984, 143(1):43-46.
87. Bessell-Browne R., O'Malley M.E. CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material. Am J Roentgenol 2007, 188(4):970-974.
88. Hurley M.E., Herts B.R., Remer E.M., et al. Three-dimensional volume-rendered helical CT before laparoscopic adrenalectomy. Radiology 2003, 229(2):581-586.
89. Johnson P., Horton K. Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics 2009, 29(5):1333-1351.
90. Hedican S.P., Marshall F.F. Adrenocortical carcinoma with intracaval extension. J Urol 1997, 158(6):2056-2061.
91. Wooten M.D., King D.K. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 1993, 72(11):3145-3155.
92. Wajchenberg B.L., Albergaria Pereira M.A., Medonca B.B., et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000, 88(4):711-736.
93. Ng L., Libertino J.M. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 2003, 169(1):5-11.
94. Bharwani N., Rockall A.G., Sahdev A., et al. Adrenocortical carcinoma: the range of appearances on CT and MRI. Am J Roentgenol 2011, 196(6):W706-W714.
95. Lloyd R, De Lellis R, Heitz P. Lloyd: World Health Organization Classification of. - Google Scholar. International Agency for Research on Cancer ... 2004.
96. Fishman E.K., Deutch B.M., Hartman D.S., et al. Primary adrenocortical carcinoma: CT evaluation with clinical correlation. AJR Am J Roentgenol 1987, 148(3):531-535.
97. Schlund J, Kenney P, Brown E. Adrenocortical carcinoma: MR imaging appearance with current techniques. Journal of Magnetic.... 1995.
98. Slattery J.M., Blake M.A., Kalra M.K., et al. Adrenocortical carcinoma: contrast washout characteristics on CT. Am J Roentgenol 2006, 187(1):W21-W24.
99. Simhan J., Canter D., Teper E., et al. Adrenocortical carcinoma masquerading as a benign adenoma on computed tomography washout study. Urology 2012, 79(2):e19-e20.
100. Hussain S., Belldegrun A., Seltzer S.E., et al. Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography. AJR Am J Roentgenol 1985, 144(1):61-65.
101. Elsayes K.M., Mukundan G., Narra V.R., et al. Adrenal Masses: MR imaging features with pathologic correlation1. Radiographics 2004, 24(Suppl 1):S73-S86.
102. Mackay B., El-Naggar A., Ordonez N.G. Ultrastructure of adrenal cortical carcinoma. Ultrastruct Pathol 1994, 18(1-2):181-190.
103. Ferrozzi F., Bova D. CT and MR demonstration of fat within an adrenal cortical carcinoma. Abdom Imaging 1995, 20(3):272-274.
104. Mezhir J.J., Song J., Piano G., et al. Adrenocortical carcinoma invading the inferior vena cava: case report and literature review. Endocr Pract 2008, 14(6):721-725.
105. Hricak H., Amparo E., Fisher M., et al. Abdominal venous system: assessment using MR. Radiology 1985, 156(2):415-422.
106. Soler R., Rodríguez E., López M.F., et al. MR imaging in inferior vena cava thrombosis. Eur J Radiol 1995, 19(2):101-107.
107. Luton J.P., Cerdas S., Billaud L., et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990, 322(17):1195-1201.
108. Becherer A., Vierhapper H., Pötzi C., et al. FDG-PET in adrenocortical carcinoma. Cancer Biother Radiopharm 2001, 16(4):289-295.
109. David R., Lamki N., Fan S., et al. The many faces of neuroblastoma. Radiographics 1989, 9(5):859-882.
110. Radin R., David C.L., Goldfarb H., et al. Adrenal and extra-adrenal retroperitoneal ganglioneuroma: imaging findings in 13 adults. Radiology 1997, 202(3):703-707.
111. Krebs T.L., Wagner B.J. MR imaging of the adrenal gland: radiologic-pathologic correlation. Radiographics 1998, 18(6):1425-1440.
112. Wilson D.A., Muchmore H.G., Tisdal R.G., et al. Histoplasmosis of the adrenal glands studied by CT. Radiology 1984, 150(3):779-783.
113. Gass A., Niendorf T., Hirsch J.G. Acute and chronic changes of the apparent diffusion coefficient in neurological disorders-biophysical mechanisms and possible underlying histopathology. J Neurol Sci 2001, 186(Suppl 1):S15-S23.
114. Malayeri A.A., Khouli El R.H., Zaheer A., et al. Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. Radiographics 2011, 31(6):1773-1791.
115. Tsushima Y., Takahashi-Taketomi A., Endo K. Diagnostic utility of diffusion-weighted MR imaging and apparent diffusion coefficient value for the diagnosis of adrenal tumors. J Magn Reson Imaging 2009, 29(1):112-117.
116. Chandarana H., Taouli B. Diffusion and perfusion imaging of the liver. Eur J Radiol 2010, 76(3):348-358.
117. Miller F.H., Wang Y., McCarthy R.J., et al. Utility of diffusion-weighted MRI in characterization of adrenal lesions. Am J Roentgenol 2010, 194(2):W179-W185.
118. Sandrasegaran K., Patel A.A., Ramaswamy R., et al. Characterization of adrenal masses with diffusion-weighted imaging. Am J Roentgenol 2011, 197(1):132-138.
119. Song J., Zhang C., Liu Q., et al. Utility of chemical shift and diffusion-weighted imaging in characterization of hyperattenuating adrenal lesions at 3.0T. Eur J Radiol 2011, [Epub ahead of print].
120. Silva A.C., Morse B.G., Hara A.K., et al. Dual-energy (spectral) CT: applications in abdominal imaging. Radiographics 2011, 31(4):1031-1046.
121. Gupta R.T., Ho L.M., Marin D., et al. Dual-energy CT for characterization of adrenal nodules: initial experience. Am J Roentgenol 2010, 194(6):1479-1483.
122. Gnannt R., Fischer M., Goetti R., et al. Dual-energy CT for characterization of the incidental adrenal mass: preliminary observations. Am J Roentgenol 2012, 198(1):138-144.
123. Yeh B.M., Shepherd J.A., Wang Z.J., et al. Dual-energy and low-kVp CT in the abdomen. Am J Roentgenol 2009, 193(1):47-54.